Abrahantes Y

Antiretroviral drug resistance in HIV-1 therapy-naive patients in Cuba

Autores: Abrahantes Y, Aleman Y, Alvarez A, Álvarez D, Aragonés C, Beheydt G, Campos J, Correa C, Dekeersmaeker N, Fonseca C, Imbrechts S, Kourí V, Martínez O, Perez J, Perez L, Schrooten Y, Soto Y, Van Laethem K, Vandamme AM, Vinken L
Ano de Publicação: 2013
Link: http://www.ncbi.nlm.nih.gov/pubmed/23416260

In Cuba, antiretroviral therapy rollout started in 2001 and antiretroviral therapy coverage has reached almost 40% since then. The objectives of this study were therefore to analyze subtype distribution, and level and patterns of drug resistance in therapy-naive HIV-1 patients.
Ler mais

Performance of an In-House Human Immunodeficiency Virus Type 1 Genotyping System for Assessment of Drug Resistance in Cuba

Autores: Abrahantes Y, Aleman Y, Alvarez A, AM, Correa C, Fonseca C, K, Kour V, Perez J, Perez L, Schrooten, Soto Y, Van Laethem, Vandamme, Vinken L, Y
Ano de Publicação: 2015
Journal: PLoS One
Link: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324769/

As commercial human immunodeficiency virus type 1 drug resistance assays are expensive, they are not commonly used in resource-limited settings. Hence, a more affordable in-house procedure was set up taking into account the specific epidemiological and economic circumstances of Cuba. The performance characteristics of the in-house assay were evaluated using clinical samples with various subtypes and resistance patterns
Ler mais

Abrahantes Y

Antiretroviral drug resistance in HIV-1 therapy-naive patients in Cuba

Performance of an In-House Human Immunodeficiency Virus Type 1 Genotyping System for Assessment of Drug Resistance in Cuba

Footer

Siga-nos

Receber a “newsletter”